Precision BioSciences, Inc.
DTIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26 | $42 | $105 | $434 |
| - Cash | $86 | $117 | $190 | $144 |
| + Debt | $30 | $31 | $27 | $9 |
| Enterprise Value | -$30 | -$43 | -$58 | $300 |
| Revenue | $69 | $49 | $25 | $116 |
| % Growth | 41% | 94.1% | -78.3% | – |
| Gross Profit | $69 | $49 | $25 | $116 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $14 | -$32 | -$63 | -$20 |
| % Margin | 19.7% | -65.8% | -250.2% | -17.5% |
| Net Income | $7 | -$61 | -$112 | -$31 |
| % Margin | 10.4% | -125.8% | -444.8% | -26.5% |
| EPS Diluted | 1.04 | -15.96 | -38.1 | -15.6 |
| % Growth | 106.5% | 58.1% | -144.2% | – |
| Operating Cash Flow | -$58 | -$84 | -$46 | -$11 |
| Capital Expenditures | -$0 | -$2 | -$3 | -$6 |
| Free Cash Flow | -$59 | -$86 | -$49 | -$17 |